FlexBiosys Joins Repligen 12th, 2023

Repligen today entered an agreement to acquire FlexBiosys Inc. of Branchburg, NJ. The acquisition is another step in building out Repligen’s Fluid Management franchise, adding a full range of single-use bioprocessing bags and assemblies to our product offering. The addition of FlexBiosys complements and vertically integrates our systems offering, providing a more complete single-use fluid … Continue reading FlexBiosys Joins Repligen →

New 3D Bag Manufacturing Equipment 31st, 2022

FlexBiosys will complete qualification of State of the Art, custom 3D bag manufacturing equipment during Q1, 2023. The equipment will increase 3D bag manufacturing capacity while maintaining the superior product robustness, quality and functionality that our customer demand for their applications.

Injection Molding Capability 31st, 2022

FlexBiosys has added additional capacity to mold custom fitments for bags and bottles. The new machines and molds provide both capacity, material control, and security of supply for critical custom components.

Expanded Capacity 28th, 2021

FlexBiosys is proud to announce that we will be expanding our capacity into a newly purchased facility in Q3 of 2022.

Frozen Bags 18th, 2021

Need a bag with low temperature application? FlexBiosys has multiple film options to best fulfill your need! One available product line, built with our premium FLEXCLR film, standard ports, and TPE tubing, has been rigorously tested beyond normal freeze-thaw cycles.

Operation Warp Speed 30th, 2020

FlexBiosys, Inc. has accepted the opportunity to work with industry leaders as a part of Operation Warp Speed, an initiative toward the race for the COVID-19 vaccine.